A Look at Globus Medical’s Segmental Performance
Globus Medical (GMED) classifies its products into innovative fusion products and disruptive technology products. Sales of innovative fusion products rose to $80.2 million in 3Q17 compared to $68.4 million in 3Q16. The increase was attributable to the increase from Alphatec’s international sales.